Doris Svetlik

1.5k total citations
25 papers, 1.1k citations indexed

About

Doris Svetlik is a scholar working on Psychiatry and Mental health, General Health Professions and Physiology. According to data from OpenAlex, Doris Svetlik has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 7 papers in General Health Professions and 7 papers in Physiology. Recurrent topics in Doris Svetlik's work include Dementia and Cognitive Impairment Research (19 papers), Alzheimer's disease research and treatments (6 papers) and Geriatric Care and Nursing Homes (4 papers). Doris Svetlik is often cited by papers focused on Dementia and Cognitive Impairment Research (19 papers), Alzheimer's disease research and treatments (6 papers) and Geriatric Care and Nursing Homes (4 papers). Doris Svetlik collaborates with scholars based in United States and Germany. Doris Svetlik's co-authors include Myron Weiner, Kristin Martin‐Cook, Catherine S. Fontaine, Betty Foster, Richard C. Risser, Linda S. Hynan, Anne M. Lipton, Roger N. Rosenberg, Klaus von Bergmann and C. Munro Cullum and has published in prestigious journals such as Biological Psychiatry, The Journal of Clinical Psychiatry and Psychiatric Services.

In The Last Decade

Doris Svetlik

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Svetlik United States 16 540 344 225 137 107 25 1.1k
V Chandra United States 14 724 1.3× 556 1.6× 132 0.6× 65 0.5× 129 1.2× 23 1.4k
Seong Yoon Kim South Korea 24 762 1.4× 394 1.1× 149 0.7× 167 1.2× 135 1.3× 81 1.7k
Rory H. Fisher Canada 15 485 0.9× 533 1.5× 121 0.5× 72 0.5× 243 2.3× 32 1.5k
Edgar Nunes de Moraes Brazil 21 397 0.7× 275 0.8× 273 1.2× 60 0.4× 84 0.8× 85 1.3k
Melinda Lantz United States 16 337 0.6× 315 0.9× 154 0.7× 90 0.7× 89 0.8× 34 930
Kati Juva Finland 18 541 1.0× 280 0.8× 118 0.5× 46 0.3× 39 0.4× 31 1.1k
P Greiner United States 11 472 0.9× 394 1.1× 137 0.6× 78 0.6× 80 0.7× 23 1.1k
Cássio Machado de Campos Bottino Brazil 17 688 1.3× 298 0.9× 164 0.7× 97 0.7× 64 0.6× 47 1.2k
Ólafur Aevarsson Sweden 13 632 1.2× 427 1.2× 73 0.3× 131 1.0× 84 0.8× 17 1.2k

Countries citing papers authored by Doris Svetlik

Since Specialization
Citations

This map shows the geographic impact of Doris Svetlik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Svetlik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Svetlik more than expected).

Fields of papers citing papers by Doris Svetlik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Svetlik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Svetlik. The network helps show where Doris Svetlik may publish in the future.

Co-authorship network of co-authors of Doris Svetlik

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Svetlik. A scholar is included among the top collaborators of Doris Svetlik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Svetlik. Doris Svetlik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boxer, Adam L., Anne M. Lipton, Kyle Womack, et al.. (2009). An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration. Alzheimer Disease & Associated Disorders. 23(3). 211–217. 80 indexed citations
2.
Weiner, Myron, Roger N. Rosenberg, Kyle Womack, et al.. (2008). Atherosclerosis Risk Factors in American Indians With Alzheimer Disease. Alzheimer Disease & Associated Disorders. 22(3). 245–248. 9 indexed citations
3.
Williamson, Gail M., Kristin Martin‐Cook, Myron Weiner, et al.. (2005). Caregiver resentment: Explaining why care recipients exhibit problem behavior.. Rehabilitation Psychology. 50(3). 215–223. 31 indexed citations
4.
Martin‐Cook, Kristin, et al.. (2004). Responsiveness of the Quality of Life in Late-Stage Dementia Scale to Psychotropic Drug Treatment in Late-Stage Dementia. Dementia and Geriatric Cognitive Disorders. 19(2-3). 82–85. 30 indexed citations
5.
Fontaine, Catherine S., et al.. (2003). A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities. The Journal of Clinical Psychiatry. 64(6). 726–730. 43 indexed citations
6.
Weiner, Myron, Linda S. Hynan, Charles L. White, et al.. (2003). Can Alzheimer’s Disease and Dementias with Lewy Bodies be Distinguished Clinically?. Journal of Geriatric Psychiatry and Neurology. 16(4). 245–250. 29 indexed citations
7.
Weiner, Myron, Kyle Womack, Doris Svetlik, et al.. (2003). Comparison of Alzheimer’s Disease in Native Americans and Whites. International Psychogeriatrics. 15(4). 367–375. 17 indexed citations
8.
Vega, Gloria Lena, Myron Weiner, Anne M. Lipton, et al.. (2003). Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease. Archives of Neurology. 60(4). 510–510. 135 indexed citations
9.
Martin‐Cook, Kristin, et al.. (2003). Caregiver attribution and resentment in dementia care. American Journal of Alzheimer s Disease & Other Dementias®. 18(6). 366–374. 37 indexed citations
10.
Saine, Kathleen C., C. Munro Cullum, Kristin Martin‐Cook, et al.. (2002). Comparison of Functional and Cognitive Donepezil Effects in Alzheimer’s Disease. International Psychogeriatrics. 14(2). 181–185. 9 indexed citations
11.
Weiner, Myron, Kristin Martin‐Cook, Barbara M. Foster, et al.. (2000). Effects of Donepezil on Emotional/Behavioral Symptoms in Alzheimer's Disease Patients. The Journal of Clinical Psychiatry. 61(7). 487–492. 58 indexed citations
12.
Weiner, Myron, et al.. (1997). Cortisol Secretion and Alzheimer’s Disease Progression. Biological Psychiatry. 42(11). 1030–1038. 102 indexed citations
13.
Rosenberg, Roger N., Fred Baskin, R. Risser, et al.. (1997). Altered Amyloid Protein Processing in Platelets of Patients With Alzheimer Disease. Archives of Neurology. 54(2). 139–144. 109 indexed citations
14.
Weiner, Myron, Doris Svetlik, & Richard C. Risser. (1997). WHAT DEPRESSIVE SYMPTOMS ARE REPORTED IN ALZHEIMER'S PATIENTS?. International Journal of Geriatric Psychiatry. 12(6). 648–652. 32 indexed citations
15.
Rosenberg, Roger N., Ralph Richter, R. Risser, et al.. (1996). Genetic Factors for the Development of Alzheimer Disease in the Cherokee Indian. Archives of Neurology. 53(10). 997–1000. 46 indexed citations
16.
Weiner, Myron, et al.. (1993). Cortisol secretion and Alzheimer's disease progression: A preliminary report. Biological Psychiatry. 34(3). 158–161. 25 indexed citations
17.
Weiner, Myron, et al.. (1992). ACE inhibitor lacks acute effect on cognition or brain blood flow in alzheimer's disease. Drug Development Research. 26(4). 467–471. 12 indexed citations
18.
Weiner, Myron, et al.. (1991). Experiences with depression in a dementia clinic.. PubMed. 52(5). 234–8. 21 indexed citations
19.
Hussey, Leslie C., et al.. (1990). Specialty Nursing Council. Clinical Nurse Specialist. 4(1). 38–42. 4 indexed citations
20.
Waller, David, et al.. (1990). Correlates of Laxative Abuse in Bulimia. Psychiatric Services. 41(7). 797–799. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026